The Use of l-Arginine in the Management of Pre-Eclampsia and Intrauterine Growth Restriction.
作者信息
Hegde C V
机构信息
Department of OBS/GYN, T N Medical College, Mumbai, India.
出版信息
J Obstet Gynaecol India. 2012 Feb;62(1):1-2. doi: 10.1007/s13224-012-0146-8. Epub 2012 Apr 20.
Abstract
摘要
相似文献
1
The Use of l-Arginine in the Management of Pre-Eclampsia and Intrauterine Growth Restriction.
J Obstet Gynaecol India. 2012 Feb;62(1):1-2. doi: 10.1007/s13224-012-0146-8. Epub 2012 Apr 20.
2
Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction.
Placenta. 2003 Feb-Mar;24(2-3):219-26. doi: 10.1053/plac.2002.0900.
3
4
Platelet changes and subsequent development of pre-eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening.
Ultrasound Obstet Gynecol. 2002 May;19(5):443-8. doi: 10.1046/j.1469-0705.2002.00672.x.
5
Does endothelial cell activation occur with intrauterine growth restriction?
BJOG. 2002 Jul;109(7):836-9. doi: 10.1111/j.1471-0528.2002.01045.x.
6
Assessment of fetal myocardial performance in severe early onset pre-eclampsia (EO-PET) with and without intrauterine growth restriction across deteriorating stages of placental vascular resistance and links to adverse outcomes.
Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:325-333. doi: 10.1016/j.ejogrb.2017.01.014. Epub 2017 Jan 16.
7
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.
Lancet. 2003 May 3;361(9368):1511-7. doi: 10.1016/S0140-6736(03)13177-7.
8
Pre-eclampsia- an additional risk factor for cognitive impairment at school age after intrauterine growth restriction and very preterm birth.
Early Hum Dev. 2014 Feb;90(2):99-101. doi: 10.1016/j.earlhumdev.2013.12.002. Epub 2013 Dec 31.
9
Maternal tissue blood flow and oxygen saturation in pre-eclampsia and intrauterine growth restriction.
Eur J Obstet Gynecol Reprod Biol. 2014 Jul;178:148-52. doi: 10.1016/j.ejogrb.2014.03.042. Epub 2014 Apr 18.
10
Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery.
Placenta. 1997 May;18(4):269-76. doi: 10.1016/s0143-4004(97)80061-6.
引用本文的文献
1
L-Arginine and L-Citrulline for Prevention and Treatment of Pre-Eclampsia: A Systematic Review and Meta-Analysis.
BJOG. 2025 May;132(6):698-708. doi: 10.1111/1471-0528.18070. Epub 2025 Jan 12.
2
Low Birth Weight, Blood Pressure and Renal Susceptibility.
Curr Hypertens Rep. 2019 Jun 21;21(8):62. doi: 10.1007/s11906-019-0969-0.
本文引用的文献
1
L-Arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-bind controlled trial.
Clin Nutr. 2009 Jun;28(3):243-8. doi: 10.1016/j.clnu.2009.03.007. Epub 2009 Apr 8.
2
Clinical use of nitric oxide donors and L-arginine in obstetrics.
J Matern Fetal Neonatal Med. 2007 Aug;20(8):569-79. doi: 10.1080/14767050701419458.
3
Nitric oxide for preventing pre-eclampsia and its complications.
Cochrane Database Syst Rev. 2007 Apr 18;2007(2):CD006490. doi: 10.1002/14651858.CD006490.
4
Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report.
Basic Clin Pharmacol Toxicol. 2006 Aug;99(2):146-52. doi: 10.1111/j.1742-7843.2006.pto_468.x.
5
Soluble endoglin contributes to the pathogenesis of preeclampsia.
Nat Med. 2006 Jun;12(6):642-9. doi: 10.1038/nm1429. Epub 2006 Jun 4.
6
Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia.
Eur J Clin Invest. 2005 Jan;35(1):32-7. doi: 10.1111/j.1365-2362.2005.01445.x.
7
Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine).
J Matern Fetal Neonatal Med. 2004 Jun;15(6):363-6. doi: 10.1080/14767050410001725280.
8
Evidence Supporting a Beneficial Role for Long-Term L-Arginine Supplementation in High-Risk Pregnancies.
Hypertension. 2004 Jul;44(1):e1. doi: 10.1161/01.hyp.0000129825.52269.9e.
9
Dietary supplementation with L-arginine or placebo in women with pre-eclampsia.
Acta Obstet Gynecol Scand. 2004 Jan;83(1):103-7.
10
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.
Lancet. 2003 May 3;361(9368):1511-7. doi: 10.1016/S0140-6736(03)13177-7.
Zotero 插件